DTIL - Company ID 0001357874
The table below shows PRECISION BIOSCIENCES INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $10.84M | $13.00K | $18.00K | $29.00K | $576.00K | $49.90M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $13.11M | $13.35M | $12.77M | $13.59M | $13.08M | $17.23M |
PRECISION BIOSCIENCES INC reported annual revenue of $34.26M for fiscal year 2025. That is down 50.1% from $68.70M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $10.88M (FY 2018) to $34.26M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $6.80M |
| $7.33M |
| $9.13M |
| $8.55M |
| $8.77M |
| $8.53M |
| Operating income | -$9.07M | -$20.67M | -$21.88M | -$22.11M | -$21.27M | $24.15M |
| Income tax | - | - | - | - | - | - |
| Net income | -$18.44M | -$21.77M | -$23.52M | -$20.57M | -$16.43M | $32.75M |
| EPS (diluted) | -$0.75 | -$1.84 | -$2.13 | -$2.21 | -$2.25 | $4.67 |